The DOI matches its Crossref record; 33 of the 36 references it cites were found in a registry or an index.
TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
Abstract
TLS, the product of a gene commonly translocated in liposarcomas (TLS), is prototypical of a newly identified class of nuclear proteins that contain a C-terminal domain with a distinct RNA recognition motif (RRM) surrounded by Arg-Gly-Gly (RGG) repeats. Its unique N terminus serves as an essential transforming domain for a number of fusion oncoproteins in human sarcomas and leukemias. In this study we use an in vivo UV crosslinking procedure to probe the interactions of TLS with RNA. TLS is found to bind RNA in vivo and the association of TLS with RNA is rapidly diminished by treating cells with transcriptional inhibitors. This suggests that the species bound by TLS turns over rapidly. Surprisingly, the RRM was found to be dispensable for RNA binding by TLS in vivo, suggesting that at any one time most of the interactions between TLS and RNA in the cell are not sequence specific. Analysis of inter specific heterokaryons formed between human and mouse or Xenopus cells revealed that TLS engages in rapid nucleocytoplasmic shuttling, a finding confirmed by the ability of anti-TLS antibodies to trap TLS when injected into the cytoplasm of HeLa cells. Cellular fractionation experiments suggest that TLS binds to RNA in both the nucleus and cytoplasm and support the hypothesis that TLS functions as a heterogeneous ribonuclear protein (hnRNP)-like chaperone of RNA. These findings are discussed in the context of the role altered forms of TLS play in cellular transformation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another ALS and FTLD gene, FUS156, is a widely expressed, predominantly nuclear RNA-binding protein176,177”
From The neurogenetics of alternative splicing (2016) · cites this paper as [177]
Citations
Cites
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Conserved Structures and Diversity of Functions of RNA-Binding Proteins
Burd, C. G., & Dreyfuss, G. (1994) · Science · doi:10.1126/science.8036511 · Cited by 1,886
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,497
Major nucleolar proteins shuttle between nucleus and cytoplasm
Borer, R. A., Lehner, C. F., Eppenberger, H. M., & Nigg, E. A. (1989) · Cell · doi:10.1016/0092-8674(89)90241-9 · Cited by 1,113
The C-terminal domain of RNA polymerase II couples mRNA processing to transcription
McCracken, S. A., Fong, N., Yankulov, K., Ballantyne, S. M., Pan, G., Greenblatt, J., Patterson, S. D., Wickens, M., & Bentley, D. L. (1997) · Nature · doi:10.1038/385357a0 · Cited by 925
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 897
Self-citationShuttling of pre-mRNA binding proteins between nucleus and cytoplasm
Piñol-Roma, S., & Dreyfuss, G. (1992) · Nature · doi:10.1038/355730a0 · Cited by 842
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 724
May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman‐Rossi, J., Thomas, G. D., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 576
Flagged first, then by citations
3 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 350
Lepourcelet, M., Tou, L., Cai, L., Sawada, J.-I., Lazar, A. J., Glickman, J. N., Williamson, J. A., Everett, A. D., Redston, M. S., Fox, E. A., et al. (2004) · Development · doi:10.1242/dev.01579 · Cited by 91
Neumann, M., Valori, C. F., Ansorge, O., Kretzschmar, H. A., Muñoz, D. G., Kusaka, H., Yokota, O., Ishihara, K., Ang, L.-C., Bilbao, J. M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1020-6 · Cited by 90
The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties
Bertolotti, A., Bell, B., & Tora, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203207 · Cited by 87
The neurobiology of amyotrophic lateral sclerosis
Bento‐Abreu, A., Damme, P. V., Bosch, L. V. D., & Robberecht, W. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07260.x · Cited by 89
Bertrand, P., Akhmedov, A. T., Delacôte, F., Dürrbach, A., & López, B. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203048 · Cited by 86
Zakaryan, R. P., & Gehring, H. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.018 · Cited by 98
Tsai, Y.-L., Coady, T. H., Lü, L., Zheng, D., Alland, I., Tian, B., Shneider, N. A., & Manley, J. L. (2020) · Genes & Development · doi:10.1101/gad.335836.119 · Cited by 84
Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions
Ling, S. (2018) · Neural Plasticity · doi:10.1155/2018/8413496 · Cited by 85
MOS11: A New Component in the mRNA Export Pathway
Germain, H., Qu, N., Cheng, Y., Lee, E., Huang, Y., Dong, O. X., Gannon, P., Huang, S., Ding, P., Li, Y., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001250 · Cited by 80
Quantitative PCR Analysis of DNA, RNAs, and Proteins in the Same Single Cell
Ståhlberg, A., Thomsen, C., Ruff, D., & Åman, P. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.191445 · Cited by 78
PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins
Deneen, B., Welford, S. M., Ho, T., Hernandez, F., Kurland, I. J., & Denny, C. T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3897-3908.2003 · Cited by 77
Verbeeck, C., Deng, Q., DeJesus‐Hernandez, M., Taylor, G., Ceballos‐Diaz, C., Kocerha, J., Golde, T. E., Das, P., Rademakers, R., Dickson, D. W., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-53 · Cited by 79
The RGG motif proteins: Interactions, functions, and regulations
Chowdhury, M. N., & Jin, H. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1748 · Cited by 70
Sasayama, H., Shimamura, M., Tokuda, T., Azuma, Y., Yoshida, T., Mizuno, T., Nakagawa, M., Fujikake, N., Nagai, Y., & Yamaguchi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039483 · Cited by 80
FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex
Lindén, M., Thomsen, C., Grundevik, P., Jonasson, E., Andersson, D., Runnberg, R., Dolatabadi, S., Vannas, C., Santamaría, M. L., Fagman, H., et al. (2019) · EMBO Reports · doi:10.15252/embr.201845766 · Cited by 74
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 75
Transportin1: a marker of FTLD-FUS
Brelstaff, J., Lashley, T., Holton, J. L., Lees, A. J., Rossor, M. N., Bandopadhyay, R., & Révész, T. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0863-6 · Cited by 75
Renoux, A. J., & Todd, P. K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.006 · Cited by 75
Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
Yang, X., Ji, Y., Wang, W., Zhang, L., Chen, Z., Yu, M., Shen, Y., Ding, F., Gu, X., & Sun, H. (2021) · Antioxidants · doi:10.3390/antiox10071012 · Cited by 82
Jablonka, S., Hennlein, L., & Sendtner, M. (2022) · Neurological Research and Practice · doi:10.1186/s42466-021-00162-9 · Cited by 79
Akhmedov, A. T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.16.3022 · Cited by 71
Aberrant Phase Transitions: Side Effects and Novel Therapeutic Strategies in Human Disease
Verdile, V., Paola, E. D., & Paronetto, M. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00173 · Cited by 70
The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site
Liu, X., Niu, C., Ren, J., Zhang, J. Y., Xie, X., Zhu, H., Feng, W., & Gong, W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.012 · Cited by 70
Bailey, J., Shen, W., Liang, X., & Crooke, S. T. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx709 · Cited by 69
Japtok, J., Lojewski, X., Naumann, M., Klingenstein, M., Reinhardt, P., Sterneckert, J. L., Putz, S., Demestre, M., Boeckers, T. M., Ludolph, A. C., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.017 · Cited by 68
Deleon, J., & Miller, B. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00027-2 · Cited by 75
Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit
Guest, W. C., Silverman, J. M., Pokrishevsky, E., O’Neill, M. A., Grad, L. I., & Cashman, N. R. (2011) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2011.618967 · Cited by 67
RNA processing pathways in amyotrophic lateral sclerosis
van Blitterswijk, M., & Landers, J. E. (2010) · Neurogenetics · doi:10.1007/s10048-010-0239-4 · Cited by 69
Niu, C., Zhang, J. Y., Gao, F., Yang, L., Jia, M., Zhu, H., & Gong, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047056 · Cited by 66
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer
Mehta, M., Raguraman, R., Ramesh, R., & Munshi, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114569 · Cited by 69
Ravanidis, S., Kattan, F.-G., & Doxakis, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082280 · Cited by 70
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications
Moens, T. G., Cruz, S. D., Neumann, M., Shelkovnikova, T. A., Shneider, N. A., & Bosch, L. V. D. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00517-9 · Cited by 70
FUS-related proteinopathies: Lessons from animal models
Lanson, N. A., & Pandey, U. B. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.039 · Cited by 66
RNA metabolism in ALS: When normal processes become pathological
Droppelmann, C. A., Campos‐Melo, D., Ishtiaq, M., Volkening, K., & Strong, M. J. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.881377 · Cited by 63
Lee, H. J., Alirzayeva, H., Koyuncu, S., Rueber, A., Noormohammadi, A., & Vílchez, D. (2023) · Nature Aging · doi:10.1038/s43587-023-00383-4 · Cited by 63
Oyoshi, T., & Kurokawa, R. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-1 · Cited by 64
Guo, T., Wang, H., Liu, P., Xiao, Y., Wu, P., Wang, Y., Chen, B., Zhao, Q., Liu, Z., & Liu, Q. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3833 · Cited by 62
Molecular genetics of chromosome translocations involvingEWSand related family members
Kim, J., & Pelletier, J. (1999) · Physiological Genomics · doi:10.1152/physiolgenomics.1999.1.3.127 · Cited by 63
Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila
Miguel, L., Avequin, T., Delarue, M., Feuillette, S., Frébourg, T., Campion, D., & Lecourtois, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.008 · Cited by 61
Gelon, P. A., Dutchak, P. A., & Sephton, C. F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1000183 · Cited by 64
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
Ranganathan, R., Haque, S., Coley, K., Shepheard, S. R., Cooper‐Knock, J., & Kirby, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00684 · Cited by 62
Lu, Y., Lim, L., & Song, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01281-7 · Cited by 58
Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U
Lee, E. B., Russ, J., Jung, H., Elman, L. B., Chahine, L. M., Kremens, D. E., Miller, B. L., Coslett, H. B., Trojanowski, J. Q., Deerlin, V. M. V., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-9 · Cited by 58
Sukhanova, M. V., Singatulina, A. S., Pastré, D., & Lavrik, O. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197020 · Cited by 56
&cestflwr; The Hsp90 family of proteins in Arabidopsis thaliana
Krishna, P., & Gloor, G. B. (2001) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2001)006 · Cited by 360
Self-citationPost-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins
Perrotti, D., & Calabretta, B. (2002) · Oncogene · doi:10.1038/sj.onc.1206085 · Cited by 55
The impact of histone post-translational modifications in neurodegenerative diseases
Cobos, S. N., Bennett, S. A., & Torrente, M. P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.019 · Cited by 53
The oncogenic transcription factor FUS-CHOP can undergo nuclear liquid–liquid phase separation
Owen, I., Yee, D. S., Wyne, H., Perdikari, T. M., Johnson, V., Smyth, J. T., Kortum, R. L., Fawzi, N. L., & Shewmaker, F. P. (2021) · Journal of Cell Science · doi:10.1242/jcs.258578 · Cited by 53
FUS is sequestered in nuclear aggregates in ALS patient fibroblasts
Schwartz, J. C., Podell, E. R., Han, S. S. W., Berry, J. D., Eggan, K. C., & Cech, T. R. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-1007 · Cited by 54
Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010
Traub, R., Mitsumoto, H., & Rowland, L. P. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0160-0 · Cited by 54
Gascon, E., & Gao, F. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.876021 · Cited by 54
Poppe, L., Rué, L., Robberecht, W., & Bosch, L. V. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 54
Sotoca, A. M., Prange, K. H. M., Reijnders, B., Mandoli, A., Nguyen, L. N. M., Stunnenberg, H. G., & Martens, J. H. A. (2015) · Oncogene · doi:10.1038/onc.2015.261 · Cited by 51
Arenas, A., Chen, J., Kuang, L., Barnett, K. R., Kasarskis, E. J., Gál, J., & Zhu, H. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa159 · Cited by 54
FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD
Orozco, D., & Edbauer, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1077-2 · Cited by 52
RNA‐binding proteins involved in RNA localization and their implications in neuronal diseases
Tolino, M., Köhrmann, M., & Kiebler, M. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08160.x · Cited by 51
RNA-binding proteins as molecular links between cancer and neurodegeneration
Campos‐Melo, D., Droppelmann, C. A., Volkening, K., & Strong, M. J. (2014) · Biogerontology · doi:10.1007/s10522-014-9531-2 · Cited by 51
Marko, M., Vlassis, A., Guialis, A., & Leichter, M. (2012) · Gene · doi:10.1016/j.gene.2012.06.088 · Cited by 48
Blechingberg, J., Luo, Y., Bolund, L., Damgaard, C. K., & Nielsen, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046251 · Cited by 48
Ernst, E. H., Nielsen, J., Ipsen, M. B., Villesen, P., & Lykke‐Hartmann, K. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00078 · Cited by 49
Raczyńska, K. D., Ruepp, M., Brzęk, A., Reber, S., Romeo, V., Rindlisbacher, B., Heller, M., Szweykowska-Kulińska, Z., Jarmołowski, A., & Schümperli, D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv794 · Cited by 47
Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity
Oh, S.-M., Liu, Z., Okada, M., Jang, S.-W., Liu, X., Chan, C.-B., Luo, H., & Ye, K.-N. (2009) · Oncogene · doi:10.1038/onc.2009.411 · Cited by 47
Gogia, N., Sarkar, A., Mehta, A. S., Ramesh, N., Deshpande, P., Kango‐Singh, M., Pandey, U. B., & Singh, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104837 · Cited by 48
Li, K. K. C., & Lee, K. A. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002961200 · Cited by 47
Capauto, D., Colantoni, A., Lü, L., Santini, T., Peruzzi, G., Biscarini, S., Morlando, M., Shneider, N. A., Caffarelli, E., Laneve, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0884-4 · Cited by 46
Azuma, Y., Tokuda, T., Shimamura, M., Kyotani, A., Sasayama, H., Yoshida, T., Mizuta, I., Mizuno, T., Nakagawa, M., Fujikake, N., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu055 · Cited by 45
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 46
Klaric, J. A., Wüst, S., & Panier, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.668821 · Cited by 46
Thomsen, C., Grundevik, P., Elias, P., Ståhlberg, A., & Åman, P. (2013) · The FASEB Journal · doi:10.1096/fj.13-234435 · Cited by 45
Guipaud, O., Guillonneau, F., Labas, V., Praseuth, D., Rossier, J., López, B. S., & Bertrand, P. (2006) · PROTEOMICS · doi:10.1002/pmic.200600259 · Cited by 42
IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells
Shi, Y., Frost, P., Hoang, B. Q., Benavides, A., Gera, J., & Lichtenstein, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153221 · Cited by 42
RNA Degradation in Neurodegenerative Disease
Weskamp, K., & Barmada, S. J. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_5 · Cited by 41
Masuda, A., Takeda, J., & Ohno, K. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1338 · Cited by 42
Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain
Aoki, N., Higashi, S., Kawakami, I., Kobayashi, Z., Hosokawa, M., Katsuse, O., Togo, T., Hirayasu, Y., & Akiyama, H. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0984-6 · Cited by 45
Murray, D. T., & Tycko, R. (2020) · Biochemistry · doi:10.1021/acs.biochem.9b00892 · Cited by 39
Fused in Sarcoma Neuropathology in Neurodegenerative DiseasePreprint
Mackenzie, I. R., & Neumann, M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024299 · Cited by 39
Zhu, L., Li, S., Li, X., & Yin, P. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00377-7 · Cited by 41
Cohen, N. R., Hammans, S. R., Macpherson, J., & Nicoll, J. A. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0738-2 · Cited by 34
Fused in sarcoma/translocated in liposarcoma: A multifunctional DNA/RNA binding protein
Yang, S., Warraich, S. T., Nicholson, G. A., & Blair, I. P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.003 · Cited by 36
Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster
Layalle, S., They, L., Ourghani, S., Raoul, C., & Soustelle, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020904 · Cited by 36
Mashiko, T., Sakashita, E., Kasashima, K., Tominaga, K., Kuroiwa, K., Nozaki, Y., Matsuura, T., Hamamoto, T., & Endo, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712232 · Cited by 35
Casci, I., Krishnamurthy, K., Kour, S., Tripathy, V., Ramesh, N., Anderson, E. N., Marrone, L., Grant, R. A., Oliver, S. L., Gochenaur, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13383-z · Cited by 34
Davidson, Y. S., Robinson, A., Hu, Q., Mishra, M., Baborie, A., Jaros, E., Perry, R. H., Cairns, N. J., Richardson, A. M. T., Gerhard, A., et al. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01274.x · Cited by 38
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 36
Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS
Gittings, L. M., Foti, S. C., Benson, B. C., Gami‐Patel, P., Isaacs, A. M., & Lashley, T. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0673-y · Cited by 34
Maggio, S., Ceccaroli, P., Polidori, E., Cioccoloni, A., Stocchi, V., & Guescini, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112804 · Cited by 34
Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis
Jeon, Y., Kwon, Y., Lee, S., & Kim, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1047897 · Cited by 34
RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains
Alex, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki270 · Cited by 34
The role of RNA processing in the pathogenesis of motor neuron degeneration
Bäumer, D., Ansorge, O., Almeida, M., & Talbot, K. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001523 · Cited by 34
Colombrita, C., Onesto, E., Tiloca, C., Ticozzi, N., Silani, V., & Ratti, A. (2011) · PubMed · doi:10.4449/aib.v149i1.1261 · Cited by 32
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
Laneve, P., Tollis, P., & Caffarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910285 · Cited by 32
Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS
Bourefis, A.-R., Campanari, M., Buée‐Scherrer, V., & Kabashi, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104935 · Cited by 35
Troakes, C., Hortobágyi, T., Vance, C. A., Al‐Sarraj, S., Rogelj, B., & Shaw, C. E. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01300.x · Cited by 32
Mori, F., Tanji, K., Kon, T., Odagiri, S., Hattori, M., Hoshikawa, Y., Kono, C., Yasui, K., Yokoi, S., Hasegawa, Y., et al. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01217.x · Cited by 31
A look into the future of ALS research
Clerc, P., Lipnick, S., & Willett, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.002 · Cited by 30
The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis
Vanneste, J., & Bosch, L. V. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212175 · Cited by 32
Thelin, S., Göransson, M., Burguete, A. S., Olofsson, A., & Åman, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1632 · Cited by 30
Ho, W. Y., Agrawal, I., Tyan, S.-H., Sanford, E., Chang, W., Lim, K., Ong, J. Z. L., Tan, B. S. Y., Moe, A. A. K., Yu, R., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01111-4 · Cited by 29
DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner
Fortuna, T. R., Kour, S., Anderson, E. N., Ward, C., Rajasundaram, D., Donnelly, C., Hermann, A., Wyne, H., Shewmaker, F., & Pandey, U. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02333-z · Cited by 25
Leichter, M., Marko, M., Ganou, V., Patrinou-Georgoula, M., Tora, L., & Guialis, A. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.09.008 · Cited by 29
Metadata
- Authors
- Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D.
- Affiliations
- Skirball Institute of Biomolecular Medicine, the Departments of Medicine, Cell Biology and the Kaplan Cancer Center, NYU Medical Center, New York, NY 10016, USA
- NYU Langone Health (US)
- ORCID
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1997-08-01
- Volume
- 110
- Issue
- 15
- Pages
- 1741-1750
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2115670698
- Cited by
- 350
- References
- 36
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 5 · 2023: 14 · 2022: 17 · 2021: 19 · 2020: 22 · 2019: 13 · 2018: 21 · 2017: 14 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 17 · 2012: 29
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cell Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca060945-09)
- National Cancer Institute (CA-60945)
- National Institute of General Medical Sciences (5T32GM07038)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Keywords
- TLS, RNA recognition motif, RNA binding, nucleocytoplasmic shuttling, fusion oncoproteins, cell transformation, transcription inhibitors, heterokaryons, UV crosslinking
- MeSH terms
- Animals, Cell Nucleus, Centrifugation, Density Gradient, Cytoplasm, Dactinomycin, HeLa Cells, Humans, Ribonucleoproteins, RNA, Ultraviolet Rays, Xenopus, RNA-Binding Proteins, Coculture Techniques, Nucleic Acid Synthesis Inhibitors, COS Cells, Heterogeneous-Nuclear Ribonucleoproteins, RNA-Binding Protein FUS, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review